A detailed history of Barnes Wealth Management Group, Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Barnes Wealth Management Group, Inc holds 1,320 shares of ABBV stock, worth $246,562. This represents 0.18% of its overall portfolio holdings.

Number of Shares
1,320
Previous 1,261 4.68%
Holding current value
$246,562
Previous $224 Million 23.45%
% of portfolio
0.18%
Previous 0.15%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

BUY
$169.2 - $216.66 $9,982 - $12,782
59 Added 4.68%
1,320 $277 Million
Q4 2024

May 12, 2025

BUY
$164.99 - $203.87 $208,052 - $257,080
1,261 New
1,261 $224 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $330B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Barnes Wealth Management Group, Inc Portfolio

Follow Barnes Wealth Management Group, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barnes Wealth Management Group, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Barnes Wealth Management Group, Inc with notifications on news.